TSP Stock Overview
TruSpine Technologies PLC, a medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
TruSpine Technologies Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0055 |
| 52 Week High | UK£0 |
| 52 Week Low | UK£0 |
| Beta | 0.54 |
| 11 Month Change | -15.38% |
| 3 Month Change | -54.17% |
| 1 Year Change | -50.00% |
| 33 Year Change | -92.81% |
| 5 Year Change | n/a |
| Change since IPO | -98.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSP | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 5.6% | -0.3% |
| 1Y | -50.0% | -1.6% | 6.1% |
Return vs Industry: TSP underperformed the UK Medical Equipment industry which returned -1.6% over the past year.
Return vs Market: TSP underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
| TSP volatility | |
|---|---|
| TSP Average Weekly Movement | 8.9% |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: TSP's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: TSP's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3 | Ian Roberts | www.truspine.org |
TruSpine Technologies PLC, a medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States. Its products include Cervi-LOK, a screw free spinal stabilization system for cervical and upper thoracic spine; Faci-LOK, a system for lumbar and lower thoracic spine, and GRASP Laminoplasty system, a treatment for decompression of the spinal cord. TruSpine Technologies PLC was incorporated in 2014 and is based in London, the United Kingdom.
TruSpine Technologies Plc Fundamentals Summary
| TSP fundamental statistics | |
|---|---|
| Market cap | UK£841.65k |
| Earnings (TTM) | -UK£471.89k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs TSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSP income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£471.89k |
| Earnings | -UK£471.89k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 10.9% |
How did TSP perform over the long term?
See historical performance and comparison